APROGEN
Aprogen is a unique biotechnology venture. Based on long-term basic scientific research results, Aprogen has accumulated unique and innovative protein drug development technologies. They have developed the antibody biosimilars for the first time in Korea and have been transferred to other companies. Since then, they have been developing protein and antibody drug design technology, high efficiency cell line manufacturing technology for antibody drug production, mass production technology of antib... ody drug using bioreactor , Drug efficacy, and pharmacological characterization technology, they now have unparalleled technology and R & D infrastructure to compete with major overseas pharmaceutical companies. Aprogen's bio business strategy is to develop innovative biopharmaceuticals based on global technological competitiveness and to develop biosimilars products with high clinical effectiveness as long-term proven and marketable biosimilars as blockbuster biopharmaceuticals.
APROGEN
Industry:
Biotechnology
Founded:
2000-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.aprogen.com
Total Employee:
11+
Status:
Active
Contact:
031-625-4045
Total Funding:
20 B KRW
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apache Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS JQuery CDN
Current Employees Featured
Founder
Investors List
Lindeman Asia Global Pioneer
Lindeman Asia Global Pioneer investment in Venture Round - Aprogen
Official Site Inspections
http://www.aprogen.com Semrush global rank: 3.7 M Semrush visits lastest month: 3.74 K
- Host name: 123.141.228.75
- IP address: 123.141.228.75
- Location: Seongnam-si South Korea
- Latitude: 37.4388
- Longitude: 127.1396
- Timezone: Asia/Seoul
- Postal: 13332
